Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.72 is 12% below its 5-year average of -0.64, near the low end of its 5-year range (-0.78–-0.52).
10.77% below its 12-month average of -0.65.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.19.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.72
EARNINGS PER SHARE (EPS) AVG TTM
-0.65
EARNINGS PER SHARE (EPS) AVG 3Y
-0.60
EARNINGS PER SHARE (EPS) AVG 5Y
-0.64
EARNINGS PER SHARE (EPS) AVG 10Y
-0.64
EARNINGS PER SHARE (EPS) AVG 15Y
-1.15
EARNINGS PER SHARE (EPS) AVG 20Y
-1.43
CURRENT VS TTM AVG
-10.77%
CURRENT VS 3Y AVG
-19.01%
CURRENT VS 5Y AVG
-12.21%
CURRENT VS 10Y AVG
-12.02%
CURRENT VS 15Y AVG
+37.35%
CURRENT VS 20Y AVG
+49.55%
DiaMedica Therapeutics Inc.
Market Cap
$457.20M
Earnings Per Share (EPS)
-0.72
TTM Avg
-0.65
3Y Avg
-0.60
5Y Avg
-0.64
Market Cap
$462.71M
Earnings Per Share (EPS)
-1.73
TTM Avg
-1.90
3Y Avg
-1.16
5Y Avg
-1.16
Market Cap
$465.59M
Earnings Per Share (EPS)
-1.98
TTM Avg
-3.65
3Y Avg
-4.15
5Y Avg
-2.79
Market Cap
$443.61M
Earnings Per Share (EPS)
0.55
TTM Avg
-3.62
3Y Avg
-10.86
5Y Avg
-15.74
Market Cap
$472.58M
Earnings Per Share (EPS)
-0.04
TTM Avg
-0.10
3Y Avg
-0.16
5Y Avg
-0.22
Market Cap
$434.84M
Earnings Per Share (EPS)
-2.45
TTM Avg
-1.70
3Y Avg
-1.35
5Y Avg
-1.20
Market Cap
$432.00M
Earnings Per Share (EPS)
-0.75
TTM Avg
-2.34
3Y Avg
-2.48
5Y Avg
-2.46
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | $457.20M | -0.72 | -0.65 | -0.60 | -0.64 |
| NRC Health (NRC)vs › | $462.23M | 0.25 | 0.79 | 1.03 | 1.18 |
| Contineum Therapeutics, Inc. (CTNM)vs › | $462.71M | -1.73 | -1.90 | -1.16 | -1.16 |
| Kamada Ltd. (KMDA)vs › | $463.29M | 0.38 | 0.32 | 0.19 | 0.19 |
| NeoGenomics, Inc. (NEO)vs › | $465.59M | -1.98 | -3.65 | -4.15 | -2.79 |
| Assembly Biosciences, Inc. (ASMB)vs › | $443.61M | 0.55 | -3.62 | -10.86 | -15.74 |
| Cerus Corporation (CERS)vs › | $472.58M | -0.04 | -0.10 | -0.16 | -0.22 |
| Capricor Therapeutics, Inc. (CAPR)vs › | $434.84M | -2.45 | -1.70 | -1.35 | -1.20 |
| Editas Medicine, Inc. (EDIT)vs › | $432.00M | -0.75 | -2.34 | -2.48 | -2.46 |
| Arvinas, Inc. (ARVN)vs › | $478.75M | 0.16 | -2.02 | -3.99 | -3.80 |
Trailing EPS (TTM)
$-0.72
Forward EPS (Est.)
$-0.77
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.70 |
| 2024-12-31 | -0.60 |
| 2023-12-31 | -0.60 |
| 2022-12-31 | -0.52 |
| 2021-12-31 | -0.65 |
| 2020-12-31 | -0.78 |
| 2019-12-31 | -0.89 |
| 2018-12-31 | -0.74 |
| 2017-12-31 | -0.72 |
| 2016-12-31 | -0.47 |
| 2015-12-31 | -0.40 |
| 2014-12-31 | -1.55 |
| 2013-12-31 | -2.71 |
| 2012-12-31 | -4.11 |
| 2011-12-31 | -2.93 |
| 2010-12-31 | -2.98 |
| 2009-12-31 | -2.54 |
| 2008-12-31 | -2.04 |
| 2007-12-31 | -2.91 |
| 2006-12-31 | -0.89 |
| 2005-12-31 | -0.24 |
| 2004-12-31 | -0.02 |
